PCMC
APLT

Planning Capital Management Corporation’s Applied Therapeutics APLT Stock Holding History

Planning Capital Management Corporation’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$68 Buy
8
+3
+60% +$18 ﹤0.01% 728
2024
Q2 		$24 Buy
+5
New +$24 ﹤0.01% 702

Other funds holding APLT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Planning Capital Management Corporation's APLT Position: Q3 2024 in Review

Planning Capital Management Corporation increased its Applied Therapeutics (APLT) stake by 60% in Q3 2024, buying an estimated $18 and bringing the position to 8 shares worth $68. The position accounts for ﹤0.01% of the portfolio, ranked #728.

Planning Capital Management Corporation first reported a position in APLT in Q2 2024 and has held it in 2 quarters since. 126 funds tracked by Wall St. Rank hold APLT as of Q3 2024.

  • Planning Capital Management Corporation held 8 shares of Applied Therapeutics worth $68 as of Q3 2024.
  • Planning Capital Management Corporation bought 3 Applied Therapeutics shares in Q3 2024, an estimated $18.
  • Applied Therapeutics made up ﹤0.01% of Planning Capital Management Corporation's portfolio in Q3 2024, its #728 holding.
  • Planning Capital Management Corporation first reported a position in Applied Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • 126 funds tracked by Wall St. Rank held Applied Therapeutics as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.